Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses PSA testing guidelines.
Apalutamide Outperforms Enzalutamide in mCSPC Survival
November 8th 2024In an interview with Targeted Oncology, Neal Shore, MD, FACS, discussed the background, findings, and implications of a real-world study of enzalutamide and apalutamide in patients with metastatic castration-sensitive prostate cancer.
Read More